UTRGV International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover)

摘要 德克萨斯大学格兰德河谷分校（UTRGV）是美国第二大西班牙裔服务机构， 2015年成立了医学院（SOM），以解决代表性不足的健康需求 少数民族（URM）人口的南得克萨斯州的美国-墨西哥边境。2017年，作为其使命的一部分， 开始主持一个关于健康差距的年度研究会议。这次会议是年的第一次此类会议。 格兰德河流域。到目前为止，一半以上的参与者是城市管理机构和妇女。每年 自2017年以来，UTRGV举办了一次健康差异研究会议，吸引了300多名与会者 每年.在美国和墨西哥边境机构的预期参与下，UTRGV-SOM将主办 第五届和第六届会议将于2022年9月9日至10日和2023年9月8日至9日举行。标题将是“国际 健康差距会议：阿片类和酒精使用障碍及相关疾病的治疗和康复 合并症（ICHD-Recover）。阿片类药物和酒精使用障碍是重要的国家公共卫生问题 在URM人群中尤为严重。ICHD-Recover有以下具体目标： 加速国家一级和美国各地研究人员之间的合作-墨西哥边境，2）到 促进与社区利益相关者的参与和合作， 文化上相关的干预措施，从而获得社区对药物使用障碍研究的支持，3） 刺激针对URM健康的新研究路线，重点关注阿片类药物和酒精使用障碍， 4）激励来自URM人群的学员参与药物滥用研究， 和5）向研究人员和卫生政策传播格兰德河流域的研究成果 其他边境地区和国家的制造商。拟议的会议将包括国家一级的会议。 已知的发言人，全体会议，摘要和海报提出的学生，研究人员，研究员，教师， 以及来自美国和邻近墨西哥边境机构的专业人士。我们75%的 演讲者来自URM。资金将用于1）邀请领先的研究人员，健康差距专家和年轻人 科学家，从美国边境地区和墨西哥，和2）实施拟议的科学议程超过两个 天，从而展示了社区参与的研究，其中研究人员和从业人员解决阿片类药物和 URM人群中酒精使用障碍的健康差异。ICHD-Recover与NIH密切相关 使命，即支持全球阿片类药物和酒精使用障碍和健康差异研究，以推进 科学知识，并帮助所有受影响的人从阿片类药物和酒精滥用的后果中恢复过来。 ICHD-Recover会议将：1）强调医学研究界如何最有效地 与社区利益相关者互动，考虑健康的社会决定因素，为设计提供信息， 实施社区干预方案，2）解决患有 阿片类药物和酒精滥用的后果以及URM人群中的相关合并症。

ABSTRACT The University of Texas Rio Grande Valley (UTRGV), the second largest Hispanic-serving institution in the nation, founded the School of Medicine (SOM) in 2015 to address the health needs of the underrepresented minority (URM) populations of south Texas on the US-Mexico border. In 2017, as part of its mission, the SOM began hosting an annual research conference on health disparities. The conference was the first of its kind in the Rio Grande Valley (RGV). To date, more than half the participants have been URMs and women. Each year since 2017 UTRGV has held a health disparities research conference that has attracted more than 300 attendees each year. With expected participation from both US and Mexico border institutions, the UTRGV-SOM will host the 5th and 6th conferences on September 9-10, 2022, and September 8-9, 2023. The title will be “International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover).” Opioid and alcohol use disorders are significant national public health problems and are particularly severe among URM populations. The ICHD-Recover has the following Specific Aims: 1) To accelerate collaborations among researchers at the national level and across the U.S.-Mexico border, 2) To facilitate engagement and collaboration with community stakeholders in research and implementation of culturally relevant interventions, thus obtaining community support for research on substance use disorders, 3) To stimulate new lines of research addressing URM health with a focus on opioid and alcohol use disorders and related comorbidities, 4) To motivate trainees from URM populations to engage in substance abuse research, and 5) To disseminate research findings from the Rio Grande Valley (RGV) to researchers and health policy makers in other border regions and states and the nation. The proposed conferences will include nationally known speakers, plenary sessions, abstracts, and posters presented by students, researchers, fellows, faculty, and professionals from the U.S. and neighboring Mexican border institutions. Seventy five percent of our speakers are from URM. Funds will be used to 1) invite leading researchers, health disparity experts and young scientists, from the U.S. border regions and Mexico, and 2) implement the proposed scientific agenda over two days, thus showcasing community-engaged research in which researchers and practitioners address opioid and alcohol use disorder health disparities in URM populations. The ICHD-Recover closely aligns with the NIH mission, which is to support global opioid and alcohol use disorders and health disparities research to advance scientific knowledge and aid all those affected to recover from the consequences of opioid and alcohol misuse. The ICHD-Recover conferences will, 1) emphasize how the medical research community can most effectively interact with community stakeholders, considering the social determinants of health to inform the design and implementation of community intervention programs, and 2) address health disparities in persons suffering from the consequences of opioid and alcohol misuse and associated comorbidities in URM populations.